These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 19280776)
1. [Malnutrition in children with DAMP?]. Andersen LL Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776 [No Abstract] [Full Text] [Related]
2. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial. Işeri E; Kiliç BG; Senol S; Karabacak NI Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944 [TBL] [Abstract][Full Text] [Related]
4. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
6. Methylphenidate euphoria. Corrigall R; Ford T J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903 [No Abstract] [Full Text] [Related]
7. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants. Ghanizadeh A Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459 [No Abstract] [Full Text] [Related]
8. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
9. Drugs and children. Pinkham JR ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805 [No Abstract] [Full Text] [Related]
10. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Diller LH Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521 [No Abstract] [Full Text] [Related]
11. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. El-Zein RA; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS; Abdel-Rahman SZ Cancer Lett; 2006 Jan; 231(1):146-8. PubMed ID: 16290920 [No Abstract] [Full Text] [Related]
12. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death. Knight M Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281 [No Abstract] [Full Text] [Related]
13. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Stasik D; Tucha O; Tucha L; Walitza S; Lange KW Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788 [TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder: part III. Ryan-Krause P J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408 [No Abstract] [Full Text] [Related]
15. Transdermal methylphenidate (Daytrana) for ADHD. Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850 [No Abstract] [Full Text] [Related]
16. ADHD remains clinical challenge: data indicate need for closer follow-up of treated children. Golden W; Kinggard TE J Ark Med Soc; 2007 Jun; 103(12):297-8. PubMed ID: 17585709 [No Abstract] [Full Text] [Related]
17. Treatment of hyperactivity in children with pervasive developmental disorders. Scahill L; Pachler M J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238 [No Abstract] [Full Text] [Related]
18. Focalin XR for ADHD. Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368 [No Abstract] [Full Text] [Related]
19. Explosive outbursts associated with methylphenidate. Adrian N J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335 [No Abstract] [Full Text] [Related]
20. ADHD, methylphenidate and driving: does some legislation endanger public health? Verster JC; Cox DJ J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623 [No Abstract] [Full Text] [Related] [Next] [New Search]